The DHEA counters
hypertension
(Le Express.fr,24/7/03)
This hormone could look after
the excess of tension of the pulmonary arteries. Researchers of Bordeaux
have just proven of it on an animal model. Remain to confirm at the man
Is this the effect of the DHEA? At 76 years spent, Pr Etienne-Emile Baulieu
lost anything neither of its ardour nor of its curiosity. In its office of
the Academy of Science, quay Conti (Paris VIe), celebrates it
endocrinologist, who acknowledges to take each day 25 Mg of
dehydroepiandrosterone (the erudite name of this substance), holds up the
study of two young researchers of Bordeaux, Sebastien Bonnet and Eric
Dumas-of-the-Castling. It will be published soon in prestigious Proceedings
of the National Academy of Sciences (reports of the American Academy of
Science).
"Never I did not see a scientific article accepted also quickly by a reading
panel, specify it, filled with wonder. This work opens an extraordinary
track. They reveal a property of the prasterone (another name of DHEA) which
could make it possible to treat pulmonary arterial hypertension."
Admittedly, the experiments were undertaken until now only on rats. But from
the clinical trials will be led at the man to the university hospital
complex of Bordeaux. This discovery starts again the interest for a
molecule, at one time presented like the "Fountain of Youth", the "pill
miracle", able to repair the insults of the years, but very decriee these
two last years.
Sebastien Bonnet and Eric Dumas-of-the-Castling, of the laboratory of
physiology of the university Bordeaux II, chose to evaluate the effects of
the DHEA on pulmonary arterial hypertension, a very widespread pathology
among large smokers. The contracting of the bronchi causes respiratory
difficulties which, in their turn, can involve an excessive increase in the
blood pressure. This complication touches 50 000 French. The risk is mortal.
In their experiments, the researchers of Bordeaux reproduced the process
while making breathe with rats of the air low in oxygen. The animals which
had received an amount of DHEA did not develop hypertension. Those which had
been exposed without precaution were partly cured after injection of this
substance. How does it act? Answer of Sebastien Bonnet and Eric
Dumas-of-the-Castling: the DHEA modulates certain ionic channels, these tiny
switches which control the electric signals in the body.
Quantitatively, it is the most significant hormone of the human body
For Michel Lazdunski, director of Institute of the molecular and cellular
pharmacology of CNRS (Nice-Sophia-Antipolis), this discovery offers new
prospects not only to look after pulmonary arterial hypertension, but also
to include/understand the mode of action of the DHEA. "We knew already that
this molecule could open ionic channels, it explains. For the first time,
work shows that it intervenes in a precise pathology. As the ionic channels
are implied in a multitude of functions of the organization, it is not
impossible that the DHEA acts thus on a large variety of cells, not only
cardiovascular, but so nervous or muscular." Remain to bring the scientific
proof of it!
The history of the prasterone is old. But the researchers are still far from
to have bored all its mysteries. This natural hormone was discovered in 1934
by a German, Dr. Adolf Butenandt. Quantitatively, it is the most significant
hormone of the human body. In blood, it is especially present in its
sulphated form (Dhea-s). One must with Pr Etienne-Emile Baulieu have shown,
in 1960, that the molecule was secreted by the glands suprarenals (small
bodies located above each kidney). Another certainty: the rate of DHEA is a
biological marker of the age. Up to 7-8 years, the children practically do
not have any. The concentration reaches a peak between 25 and 30 years and
declines gradually. At 80 years, it does not represent any more but from 10
to 20% of its maximum level. The presence of prasterone is stronger at the
man than at the woman.
"the benefits of a catch of DHEA are not always quantifiable objectively"
Is there a therapeutic interest to make up this deficit growing by the
ingestion of gelules of synthetic DHEA? To date, only one great study -
baptized DHEAge - was carried out on the subject in France. Carried out by
Pr Francoise Forette, gerontologist, and Pr Etienne-Emile Baulieu, it
included a population of 280 volunteers, old from 60 to 79 years. A daily
amount of 50 Mg their was given during one year. Conclusion of this work,
published in April 2000: the recipients of the treatment are the women, in
particular those which exceed 70 years. The DHEA improves their bone tissue
metabolism, the quality of their skin and their libido. The effects on the
organization appear limited. Is it necessary for as much "disadvising the
regulation of the DHEA within the framework of the fight against the effects
of ageing", as wrote it, in August 2001, the director of the French Agency
of the medical safety of the products of health (Afssaps)? Certainly not.
The 50 000 French who, currently, take this substance regularly do not have
anything to fear. The DHEAge study has the merit to show that this molecule
is not dangerous. There was neither accident nor excessive accumulation of
hormones.
This work reveals, in addition, the difficulties of evaluating a substance
which acts as very many points of the organization. "the benefits of a catch
of DHEA are not always quantifiable objectively, observes Dr. Christophe de
Jaeger, doctor geriatre, author of the Techniques of fight against ageing (PUF)
and of the DHEA, myths and realities (Albin Michel). Our patients feel a
general improvement and a multitude of small positive effects. Some do not
make any more bronchitis, others do not know any more problems of
articulations."
The DHEAge study poses another methodological problem. All the volunteers
received an identical treatment, whereas the deficit of DHEA varies from one
individual to another. The variation can be 1 to 20 for the same age
bracket! That distorts the final result partly. The catches would have in
the future to be modulated, in order to take account of these differences.
The more so as before any regulation of DHEA the doctors require a blood
analysis to measure the rate of prasterone and to adapt the amount to be
taken.
Complementary studies must be undertaken on the effects of the DHEA at the
man. The obstacle to carry them out is due to the difficulties of financing.
"It is a natural molecule, therefore nonpatentable. It is in consequence
impossible to make deal with work by a pharmaceutical laboratory ",
underlines Pr Baulieu. DHEAge could be done only with the support of the
area Island-of-France, the French Foundation for medical research and of
Artemis (Pinault group). In order to continue his research, the president of
the Academy of Science needs new patrons. If not, France is likely to lose
its position in this field. There is urgency. Fault of having found a
station in the Hexagon, Sebastien Bonnet, one of the two decouvreurs of
Bordeaux, soon will be exiled in Canada....